G

Giant Biogene Holding Co Ltd
HKEX:2367

Watchlist Manager
Giant Biogene Holding Co Ltd
HKEX:2367
Watchlist
Price: 51.2 HKD -0.19% Market Closed
Market Cap: 52B HKD
Have any thoughts about
Giant Biogene Holding Co Ltd?
Write Note

Giant Biogene Holding Co Ltd
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Giant Biogene Holding Co Ltd
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
G
Giant Biogene Holding Co Ltd
HKEX:2367
Accrued Liabilities
ÂĄ40.7m
CAGR 3-Years
-40%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hengan International Group Company Ltd
HKEX:1044
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Shanghai Flyco Electrical Appliance Co Ltd
SSE:603868
Accrued Liabilities
ÂĄ166.9m
CAGR 3-Years
45%
CAGR 5-Years
27%
CAGR 10-Years
N/A
Proya Cosmetics Co Ltd
SSE:603605
Accrued Liabilities
ÂĄ186.5m
CAGR 3-Years
41%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
Accrued Liabilities
ÂĄ132.4m
CAGR 3-Years
-4%
CAGR 5-Years
8%
CAGR 10-Years
N/A
By-health Co Ltd
SZSE:300146
Accrued Liabilities
ÂĄ358.9m
CAGR 3-Years
12%
CAGR 5-Years
6%
CAGR 10-Years
N/A
No Stocks Found

Giant Biogene Holding Co Ltd
Glance View

Market Cap
52.6B HKD
Industry
Consumer products

In the bustling entrepreneurial landscape of China's Xi'an comes a formidable player in the skincare industry—Giant Biogene Holding Co Ltd. Founded in the early 2000s, the company quickly established itself as a pioneer in the biocosmetic field, underpinned by its commitment to leveraging cutting-edge biotechnologies. Positioned at the intersection of science and beauty, Giant Biogene concentrates on the research, production, and sale of bioactive skincare ingredients and products. These formulations, rich in proteins and polypeptides, target aspiring consumers eager to invest in beauty products that promise both efficacy and luxury. The company’s emphasis on integrating advanced bioengineering techniques with traditional Chinese medicinal practices has allowed it to carve out a distinct niche in the market, often emphasizing the scientific rigor and innovative spirit behind their product lines. Giant Biogene's revenue flows primarily from its comprehensive suite of skincare products, which are distributed through a variety of channels, including e-commerce platforms and retail partnerships. The company taps into the rising demand for premium anti-aging and skin-repair products in China's robust beauty market. This inclination towards advanced skincare solutions is largely fueled by an increasingly affluent middle class that places high value on personal care and appearance. The company further augments its revenue streams by developing proprietary formulas and licensing these innovative technologies to other skincare brands, thereby capitalizing on its formidable R&D capabilities. By maintaining a symbiotic relationship between its research endeavors and market strategy, Giant Biogene continues to thrive as a vanguard of scientific beauty solutions amid evolving consumer preferences.

Intrinsic Value
53.88 HKD
Undervaluation 5%
Intrinsic Value
Price
G

See Also

What is Giant Biogene Holding Co Ltd's Accrued Liabilities?
Accrued Liabilities
40.7m CNY

Based on the financial report for Dec 31, 2023, Giant Biogene Holding Co Ltd's Accrued Liabilities amounts to 40.7m CNY.

What is Giant Biogene Holding Co Ltd's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 3Y
-40%

Over the last year, the Accrued Liabilities growth was -67%. The average annual Accrued Liabilities growth rates for Giant Biogene Holding Co Ltd have been -40% over the past three years .

Back to Top